Skip to main content
Doing Life Sciences Deals

Mintz Levin logo Doing Life Sciences Deals in 2024

Doing Life Sciences Deals in 2024

Navigating the complexities of life sciences deals in 2024 can be a challenging feat given the current landscape. International Chair of Mintz’s Life Sciences practice Cheryl Reicin, dives into the key factors to consider when structuring licensing, M&A, and asset sales including competitive tension, time of year, multiple business development options, and clear communication.

Learn More

Awards and Recognition

More from Mintz

Ready to Get Started?

Our Services